HELLINGS, Niels

Email Alert RSS Feed

Profile

Full Name
HELLINGS, Niels
Email
niels.hellings@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Refined By:
Type:  Journal Contribution

Results 181-200 of 206 (Search time: 0.007 seconds).

show all
Issue DateTitleContributor(s)TypeCat.
1812006No association of leukemia inhibitory factor (LIF) DNA polymorphisms with multiple sclerosisVANDERLOCHT, Joris; BURZYKOWSKI, Tomasz; SOMERS, Veerle; STINISSEN, Piet; HELLINGS, NielsJournal ContributionA1
1822006Effects of IFN-beta, leptin and sinivastatin on LIF secretion by T lymphocytes of MS patients and healthy controlsVANDERLOCHT, Joris; HENDRIKS, Jerome; VENKEN, Koen; STINISSEN, Piet; HELLINGS, NielsJournal ContributionM
1832006Influence of leukaemia inhibitory factor on macrophage function in vitro and during experimental autoimmune encephalomyelitisHENDRIKS, Jerome; HELLINGS, Niels; VANDERLOCHT, Joris; STINISSEN, PietJournal ContributionM
1842006T-cell vaccination in MS with CSF-derived activated CD4(+) T-cells: Results of a placebo-controlled trialSTINISSEN, Piet; MEDAER, Rob; HELLINGS, Niels; Barkhof, F.; RAUS, JefJournal ContributionM
1852006Effects of IFN-beta, leptin and simvastatin on LIF secretion by T lymphocytes of MS patients and healthy controlsVANDERLOCHT, Joris; HENDRIKS, Jerome; VENKEN, Koen; STINISSEN, Piet; HELLINGS, NielsJournal ContributionA1
1862006Secondary progressive in contrast to relapsing - Remitting multiple sclerosis patients show a normal CD4(+)CD25(+) regulatory T cell function and FOXP3 expressionVENKEN, Koen; HELLINGS, Niels; HENSEN, Karen; RUMMENS, Jean-Luc; MEDAER, Rob; D'hooghe, MB; Dubois, B; RAUS, Jef; STINISSEN, PietJournal ContributionM
1872006Leukemia inhibitory factor is produced by myelin-reactive T cells from multiple sclerosis patients and protects against tumor necrosis factor-α-induced oligodendrocyte apoptosisVANDERLOCHT, Joris; HELLINGS, Niels; HENDRIKS, Jerome; VANDENABEELE, Frank; MOREELS, Marjan; BUNTINX, Mieke; Hoekstra, D.; Antel, J.; STINISSEN, PietJournal ContributionA1
1882006Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4(+)CD25(+) regulatory T-Cell function and FOXP3 expressionVENKEN, Koen; HELLINGS, Niels; HENSEN, Karen; RUMMENS, Jean-Luc; MEDAER, Rob; D'hooghe, M.; Dubois, W.; RAUS, Jef; STINISSEN, PietJournal ContributionA1
1892006T cell vaccination in multiple sclerosis with CSF-derived activated cd4+T cells: results of a placebo-controlled trialSTINISSEN, Piet; MEDAER, Rob; HELLINGS, Niels; VANROOSE, Erwin; Barkhof, F.; RAUS, JefJournal ContributionM
1902006T-cell-based immunotherapy in multiple sclerosis: induction of regulatory immune networks by T-cell vaccinationHELLINGS, Niels; RAUS, Jef; STINISSEN, PietJournal ContributionA2
1912005Profiling the autoantibody repertoire by serological antigen selectionSOMERS, Veerle; GOVARTS, Cindy; HELLINGS, Niels; Hupperts, R.; STINISSEN, PietJournal ContributionA1
1922005Diffusion of sphingomyelin and myelin oligodendrocyte glycoprotein in the membrane of OLN-93 oligodendroglial cells studied by fluorescence correlation spectroscopyGIELEN, Ellen; Vercammen, J; Sykora, J; Humpolickova, J; VAN DE VEN, Martin; Benda, A.; HELLINGS, Niels; Hof, M; Engelborghs, Y; STEELS, Paul; AMELOOT, MarcelJournal ContributionA1
1932004Impaired suppressive capacity and reduced FOXP3 expression of CD4+CD25+ regulatory T cells isolated from multiple sclerosis patientsVENKEN, Koen; HELLINGS, Niels; SCHUERMANS, Joke; RAUS, Jef; STINISSEN, PietJournal ContributionM
1942004Anti-ergotypic T cell responses in healthy controls and multiple sclerosis patientsHELLINGS, Niels; GOVARTS, Cindy; RAUS, Jef; STINISSEN, PietJournal ContributionM
1952004Leukemia inhibitory factor is produced by myelin reactive T-cells and protects against cytokine induced oligodendrocyte cell deathVANDERLOCHT, Joris; HELLINGS, Niels; VANDENABEELE, Frank; MOREELS, Marjan; Antel, J.; RAUS, Jef; STINISSEN, PietJournal ContributionM
1962004T-cell vaccination in multiple sclerosis: update on clinical application and mode of actionHELLINGS, Niels; RAUS, Jef; STINISSEN, PietJournal ContributionA1
1972003Effects of prolactin on cloned human T-LymphocytesDogusan, Z; Martens, N; STINISSEN, Piet; HELLINGS, Niels; Demotte, N; Hooghe, R; Hooghe-Peters, ELJournal ContributionA1
1982003T cell vaccination in multiple sclerosis patients with autologous CSF-derived activated T cells: results from a pilot studyVAN DER AA, Annegret; HELLINGS, Niels; MEDAER, Rob; Gelin, G; PALMERS, Yvan; RAUS, Jef; STINISSEN, PietJournal ContributionA1
1992003Functional properties of myelin oligodendrocyte glycoprotein-reactive T cells in multiple sclerosis patients and controlsVAN DER AA, Annegret; HELLINGS, Niels; Bernard, C.C.A.; RAUS, Jef; STINISSEN, PietJournal ContributionA1
2002003Potential role for neuropoietic factors in protecting oligodendrocytes from cytokine induced damageVANDERLOCHT, Joris; HELLINGS, Niels; Dreesen, E; BUNTINX, Mieke; DE RYCK, Leen; RAUS, Jef; STINISSEN, PietJournal ContributionM
show all